Ravasio, R., Antonelli, S., Maiorino, A., Costanzo, A., & Losi, S. (2019). Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy. Global &Amp; Regional Health Technology Assessment, 6(1). https://doi.org/10.33393/grhta.2019.468